Latest Blog Posts
FDA Expands Voluntary Recall of Soliris After Recieving Reports of Contamination
| December 17th, 2013
December 17, 2013 Manufacturers of the medications Americans use have a responsibility to ensure the safety of the drugs they release to consumers. The Drug Injury Attorneys with Ferrer Poirot Feller Daniel explain that failure to do so can result in costly recalls in order to ensure defective drugs don’t harm patients. The U.S. Food
Read MoreWarnings Regarding Nuclear Cardiac Stress Test Agents Issued By The FDA
| December 10th, 2013
December 10, 2013 The U.S. Food and Drug Administration (FDA) has issued a warning about health risks that are associated with the use of certain medications given to patients during cardiac nuclear stress tests. The Drug Injury Attorneys with Ferrer Poirot Feller Daniel explain officials have stated patients who are given dosages of Lexiscan (regadenoson)
Read MoreFDA Warns Of Skin Condition Risk From Taking Anti-Seizure Medication
| December 3rd, 2013
December 3, 2013 For those who suffer seizures, the medications that control this condition can be vital to leading a normal and healthy life. However, the U.S. Food and Drug Administration (FDA) recently issued a warning about the anti-seizure medication, Onfi (clobazam), and the serious harm it can cause users. The Drug Injury Lawyers with
Read MoreFDA Announces Recall of Contaminated Workout Supplement
| November 26th, 2013
November 26, 2013 Workout supplements can provide athletes and those looking to improve their bodies the edge they need to achieve their goals. However, certain types of these supplements could put users’ health in serious danger. The Workout Supplement Lawyers with the law firm of Ferrer Poirot Feller Daniel explain such risks recently led to
Read More